Evidence by expression analysis of candidate genes for congenital heart defects in the NF1 microdeletion interval

Annals of Human Genetics

Volumn 69, Issue 5, 2005, Pages 508-516

  Venturin, M ^a   Bentivegna, A ^a   Moroni, R ^a   Larizza, L ^a   Riva, Paola ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

17q11.2 genes; Congenital heart defects; Expression profile; Human fetal tissues; Mouse embryo

Indexed keywords

CENTAURIN ALPHA 2 PROTEIN; NEUROFIBROMIN; PHOSPHOLIPID BINDING PROTEIN; SUPPRESSOR OF ZESTE PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NKX2.5; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING SITE; BIOINFORMATICS; CLINICAL ARTICLE; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; EMBRYO; EMBRYO DEVELOPMENT; FETUS; FETUS HEART; GENE DELETION; GENE EXPRESSION PROFILING; GENE FUNCTION; GESTATIONAL AGE; HEART ATRIUM SEPTUM DEFECT; HEART DEVELOPMENT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; NORTHERN BLOTTING; ORTHOLOGY; PATENT DUCTUS ARTERIOSUS; PREDICTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VALVULAR HEART DISEASE;

ANIMALS; BINDING SITES; BLOTTING, NORTHERN; COMPUTATIONAL BIOLOGY; DATABASES, FACTUAL; DNA PRIMERS; GENE DELETION; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, NEUROFIBROMATOSIS 1; HEART; HEART DEFECTS, CONGENITAL; HOMEODOMAIN PROTEINS; HUMANS; MICE; MUTATION; MYOCARDIUM; NEUROFIBROMIN 1; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE DISTRIBUTION; TRANSCRIPTION FACTORS;

EID: 24944554619     PISSN: 00034800     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1529-8817.2005.00203.x     Document Type: Article

References (33)

1. Birve, A., Sengupta, A. K., Beuchle, D., Larsson, J., Kennison, J. A., Rasmuson-Lestander, A. & Muller, J. (2001) Su(z)12, a novel Drosophila Polycomb group gene that is conserved in vertebrates and plants. Development 128, 3371-3379.
2. Brand, T. (2003) Heart development: molecular insights into cardiac specification and early morphogenesis. Dev Biol 258, 1-19.
3. De Raedt, T., Brems, H., Wolkenstein, P., Vidaud, D., Pilotti, S., Perrone, F., Mautner, V., Frahm, S., Sciot, R. & Legius, E. (2003) Elevated risk for MPNST in NF1 microdeletion patients. Am J Hum Genet 72, 1288-1292.
4. Dorschner, M. O., Sybert, V. P., Weaver, M., Pletcher, B. A. & Stephens, K. (2000) NF1 microdeletion breakpoints are clustered at flanking repetitive sequences. Hum Mol Genet 9, 35-46.
5. Epstein, J. A. (2000) Developmental cardiology comes of age. Circ Res 87, 833-834.
6. Garg, V., Kathiriya, I. S., Barnes, R., Schluterman, M. K., King, I. N., Butler, C. A., Pothrock, C. R., Eapen, R. S., Hirayama-Yamada, K., Joo, K., Matsuoka, R., Cohen, J. C. & Srivastava, D. (2003) GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 424, 443-447.
7. Gelb, B. D. (2001) Genetic basis of syndromes associated with congenital heart disease. Curr Opin Cardiol 16, 188-194.
8. Gruenauer-Kloevekorn, C. & Froster, U. G. (2003) Holt-Oram syndrome: a new mutation in the TBX5 gene in two unrelated families. Ann Genet 46, 19-23.
9. Huson, S. M. & Huges, R. C. (1994) The Neurofibromatosis: a clinical and pathogenetic overview. Chapman and Hall, London.
10. Jenne, D. E., Tinschert, S., Reimann, H., Lasinger, W., Thiel, G., Hameister, H. & Kehrer-Sawatzki, H. (2001) Molecular characterization and gene content of breakpoint boundaries in patients with neurofibromatosis type 1 with 17q11.2 microdeletions. Am J Hum Genet 69, 516-527.
11. Krantz, I. D., Smith, R., Colliton, R. P., Tinkel, H., Zackai, E. H., Piccoli, D. A., Goldmuntz, E. & Spinner, N. B. (1999) Jagged1 mutations inpatients ascertained with isolated congenital heart defects. Am J Med Genet 84, 56-60.
12. Kuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P. & Reinberg, D. (2002) Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein. Genes Dev 16, 2893-2905.
13. Lin, A. E., Birch, P. H., Korf, B. P,., Tenconi, R., Niimura, M., Poyhonen, M., Armfield Uhas, K., Sigorini, M., Virdis, R., Romano, C., Bonioli, E., Wolkenstein, P., Pivnick, E. K., Lawrence, M. & Friedman, J. M. (2000) Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1. Am J Med Genet 95, 108-117.
14. Lints, T. J., Parsons, L. M., Hartley, L., Lyons, I. & Harvey, R. P. (1993) Nkx-2.5: a novel murine homeobox gene expressed in early heart progenitor cells and their myogenic descendants. Development 119, 419-431.
15. Lo, P. C., Skeath,J. B., Gajewski, K., Schulz, R. A. & Frasch, M. (2002) Homeotic genes autonomously specify the anteroposterior subdivision of the Drosophila dorsal vessel into aorta and heart. Dev Biol 251, 307-319.
16. Lovato, T. L., Nguyen, T. P., Molina, M. R. & Cripps, P. M. (2002) The Hox gene abdominal-A specifies heart cell fate in the Drosophila dorsal vessel. Development 129, 5019-5027.
17. McCright, B., Lozier, J. & Gridley, T. (2002) A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency. Development 129, 1075-1082.
18. McGinnis, W. & Krumlauf, R. (1992) Homeobox genes and axial patterning. Cell 68, 283-302.
19. Molkentin, J. D., Antos, C., Mercer, B., Taigen, T., Miano, J. M. & Olson, E. N. (2000) Direct activation of a GATA6 cardiac enhancer by Nkx2.5: evidence for a reinforcing regulatory network of Nkx2.5 and GATA transcription factors in the developing heart. Dev Biol 217, 301-309.
20. Morris, C. A. & Mervis, C. B. (2000) Williams syndrome and related disorders. Annu Rev Genomics Hum Genet 1, 461-484.
21. Oda, T., Elkahloun, A. G., Pike, B. L., Okajima, K., Krantz, I. D., Genin, A., Piccoli, D. A., Meltzer, P. S., Spinner, N. B., Collins, F. S. & Chandrasekharappa, S. C. (1997) Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet 16, 235-242.
22. Ponzielli, R., Astier, M., Chartier, A., Gallet, A., Therond, P. & Semeriva, M. (2002) Heart tube patterning in Drosophila requires integration of axial and segmental information provided by the Bithorax Complex genes and hedgehog signaling. Development 129, 4509-4521.
23. Riva, P., Corrado, L., Natacci, F., Castorina, P., Wu, B. L., Schneider, G. H., Clementi, M., Tenconi, R., Korf, B. R. & Larizza, L. (2000) NF1 microdeletion syndrome: refined FISH characterization of sporadic and familial deletions with locus-specific probes. Am J Hum Genet 66, 100-109.
24. Schott, J. J., Benson, D. W., Basson, C. T., Pease, W., Silberbach, G. M., Moak, J. P., Maron, B. J., Seidman, C. E. & Seidman, J. G. (1998) Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 281, 108-111.
25. Schultheiss, T. M., Xydas, S. & Lassar, A. B. (1995) Induction of avian cardiac myogenesis by anterior endoderm. Development 121, 4203-4214.
26. Shirai, M., Osugi, T., Koga, H., Kaji, Y., Takimoto, E., Komuro, I., Hara, J., Miwa, T., Yamauchi-Takihara, K. & Takihara, Y. (2002) The Polycomb-group gene Rae28 sustains Nkx2.5/Csx expression and is essential for cardiac morphogenesis. J Clin Invest 110, 177-184.
27. Tanaka, M., Chen, Z., Bartunkova, S., Yamasaki, N. & Izumo, S. (1999) The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development. Development 126, 1269-1280.
28. Tartaglia, M., Mehler, E. L., Goldberg, R., Zampino, G., Brunner, H. G., Kremer, H., van der Burgt, I., Crosby, A. H., Ion, A., Jeffery, S., Kalidas, K., Patton, M. A., Kucherlapati, R. S. & Gelb, B. D. (2001) Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 29, 465-468.
29. Tonsgard, J. H., Yelavarthi, K. K., Cushner, S., Short, M. P. & Lindgren, V. (1997) Do NF1 gene deletions result in a characteristic phenotype? Am J Med Genet 73, 80-86.
30. Venturin, M., Gervasini, C., Orzan, F., Bentivegna, A., Corrado, L., Colapietro, P., Friso, A., Tenconi, R., Upadhyaya, M., Larizza, L. & Riva, P. (2004a) Evidence for non-homologous end joining and non-allelic homologous recombination in atypical NF1 microdeletions. Hum Genet 115, 69-80.
31. Venturin, M., Guanieri, P., Natacci, F., Stabile, M., Tenconi, R., Clementi, M., Hernandez, C., Thompson, P., Upadhyaya, M., Larizza, L. & Riva, P. (2004b) Mental retardation and cardiovascular malformations in NF1-microdeleted patients point to candidate genes in 17q11.2. J Med Genet 41, 35-41.
32. Vourc'h, P., Dessay, S., Mbarek, O., Marouillat Vedrine, S., Muh, J. P. & Andres, C. (2003) The oligodendrocyte-myelin glycoprotein gene is highly expressed during the late stages of myelination in the rat central nervous system. Brain Res Dev Brain Res 144, 159-168.
33. Whitley, P., Gibbard, A. M., Koumanov, F., Oldfield, S., Kilgour, E. E., Prestwich, G. D. & Holman, G. D. (2002) Identification of centaurin-alpha2: a phosphatidylinositide-binding protein present in fat, heart and skeletal muscle. Eur J Cell Biol 81, 222-230.